Short Interest in Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Declines By 43.8%

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a large decline in short interest during the month of July. As of July 15th, there was short interest totaling 456 shares, a decline of 43.8% from the June 30th total of 812 shares. Currently, 0.1% of the company’s stock are sold short. Based on an average daily trading volume, of 3,103 shares, the days-to-cover ratio is currently 0.1 days.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of BOUT. Osaic Holdings Inc. increased its position in Innovator IBD Breakout Opportunities ETF by 39.7% during the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after buying an additional 597 shares during the last quarter. Susquehanna International Group LLP lifted its position in shares of Innovator IBD Breakout Opportunities ETF by 42.6% in the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after buying an additional 7,817 shares during the last quarter. Finally, Comprehensive Wealth Management LLC boosted its stake in shares of Innovator IBD Breakout Opportunities ETF by 122.0% during the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after acquiring an additional 12,859 shares in the last quarter.

Innovator IBD Breakout Opportunities ETF Price Performance

BOUT traded up $0.01 during midday trading on Friday, hitting $46.24. 1,791 shares of the company’s stock traded hands, compared to its average volume of 4,015. The company has a market cap of $16.18 million, a PE ratio of 28.69 and a beta of 1.03. The stock’s fifty day simple moving average is $47.02 and its 200-day simple moving average is $43.25. Innovator IBD Breakout Opportunities ETF has a one year low of $35.05 and a one year high of $49.41.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.